Remote Monitoring and Outcomes in Pacemaker and Defibrillator Patients

[...]the mean follow-up interval in the randomized trials was significantly less than in the observational studies that continue to see benefit out to 5 years of follow-up. [...]the observational and randomized trial published data seem to consistently demonstrate that RM of patients with cardiac implantable devices is safe, with outcomes at least comparable with those treated with in-person follow-up alone. [...]the cardiac implantable device and research communities should continue to investigate ways of optimizing and improving RM and the timely use of "big data" to improve clinical outcomes.